Zekai Zhao
- Biomedical Engineering top 5%
- Biomaterials top 2%
- Molecular Biology
- Immunology top 10%
- Materials Chemistry
- Co-authors
- Can ZhangJingwei XueLingjing XueRan MoQineng PingLingyi KongLei ZhangLu Wang
- Topics
- Nanoparticle-Based Drug Delivery (6 papers)Nanoplatforms for cancer theranostics (6 papers)Animal Virus Infections Studies (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zekai Zhao
18 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Biomedical Engineering 825
- Biomaterials 589
- Molecular Biology 496
- Immunology 303
- Materials Chemistry 170
Countries citing papers authored by Zekai Zhao
This map shows the geographic impact of Zekai Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zekai Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zekai Zhao more than expected).
Fields of papers citing papers by Zekai Zhao
This network shows the impact of papers produced by Zekai Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zekai Zhao. The network helps show where Zekai Zhao may publish in the future.
Co-authorship network of co-authors of Zekai Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Zekai Zhao. A scholar is included among the top collaborators of Zekai Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zekai Zhao. Zekai Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 18 | |
| 6 | 61 | |
| 7 | 17 | |
| 8 | 13 | |
| 9 | 35 | |
| 10 | 5 | |
| 11 | Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrencebreakdown → | 813 |
| 12 | 149 | |
| 13 | 41 | |
| 14 | 1 | |
| 15 | 205 | |
| 16 | 36 | |
| 17 | 2 | |
| 18 | 16 |
About Zekai Zhao
Zekai Zhao is a scholar working on Biomaterials, Agronomy and Crop Science and Animal Science and Zoology, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Animal Virus Infections Studies (4 papers). The work is most often cited by research in Biomaterials (589 citations), Biomedical Engineering (825 citations) and Immunology (303 citations). Zekai Zhao has collaborated with scholars based in China and United States. Frequent co-authors include Can Zhang, Jingwei Xue, Lingjing Xue, Ran Mo, Qineng Ping, Lingyi Kong, Lei Zhang, Lu Wang, Hongbin Sun and Yajing Wen. Their work appears in journals such as Angewandte Chemie International Edition, Nature Nanotechnology and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.